Genome Web Breaking News
- Congenital Hydrocephalus Exome Study Reveals Mutations in Early Brain Development Genes
- PathogenDx Partners With Prevenio on Food Safety System
- Fluidigm Shares Rise on Selection of Saliva-Based COVID-19 Assay for Federal Surge Testing
- LumiraDx Gets FDA Emergency Use Authorization for PCR-Based Coronavirus Test
- Coronavirus Testing Specimen Collection Devices From DNA Genotek, Clinical Enterprises Get FDA EUAs
Stat
- STAT Plus: Pharmalittle: Why the FDA Covid-19 vaccine meeting matters; GAO to probe whether Trump aides meddled with FDA, CDC
- STAT Plus: A conversation with Exuma Biotech’s CEO about CAR-T and China’s strategic advantages
- STAT Plus: CBC Group sets up AffaMed, EverInsight merger, eyes IPO
- Pharma contributed to attorneys general who want to repeal the Affordable Care Act
- Opinion: Cell phone numbers could provide a fast-track solution to matching patients with their health records
NYT science news
- N.Y. Accuses Religious Health Cost-Sharing Group of Misleading Consumers
- How an Ill-Fated Fishing Voyage Helped Us Understand Covid-19
- U.S. Diplomats and Spies Battle Trump Administration Over Suspected Attacks
- Seven Charged in Flying Squirrel Trafficking Ring, Florida Officials Say
- A Viral Theory Cited by Health Officials Draws Fire From Scientists
Xconomy news
- Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
- Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
- Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
- Roche Enlists Dyno to Bring AI to Next-Generation Liver, CNS Gene Therapies
- Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
Fierce Biotech
- Medtronic’s Intellis spinal cord stimulator shows back pain relief at one-year mark
- COVID-19 vaccine biotech Vaccitech nabs Pfizer, Kite vet as full-time CMO
- Compass aims at $50M IPO to push lead antibody through the clinic
- Merck's rival to Pfizer's Prevnar 13 hits goal in phase 3 again
- Covance to 'transform' into a decentralized CRO
Fierce Medical Devices
- Medtronic’s Intellis spinal cord stimulator shows back pain relief at one-year mark
- Lab survey illustrates testing delays spreading to non-COVID diagnostic areas
- LabCorp launches COVID-19 antibody test for measuring vaccine effectiveness
- Owlstone's breath-based biopsy test spots signs of declining liver function
- Genentech taps Stanford University spinout for AI drug discovery partnership